Rajendra K C

Rajendra K C

Auto-generated profile, based on publicly available information

Rajendra K C

Center for Biophysics and Quantitative Biology, University of Illinois Urbana-Champaign, Champaign, IL, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2026 in Science Advances
Verified
Journal Article
Open access
SBShruti V. Bendre
Shruti V. Bendre
YWYu Wang
Yu Wang
BHBasel Hajyousif
Basel Hajyousif
RCRajendra K C
Rajendra K C
SBShounak G. Bhogale
Shounak G. Bhogale
ENErik R. Nelson
Erik R. Nelson
Breast and other solid tumors respond poorly to immune therapy. Myeloid cells (MCs) such as macrophages contribute to resistance. Established clinical evidence links cholesterol to cancer outcomes, with MC function being regulated by cholesterol metabolism. We screened MC-expressed regulators of cholesterol homeostasis linked to survival and identified the cholesterol efflux protein ABCA1. ABCA1 activity increases anticancer functions of macrophages: enhancing tumor infiltration, decreasing angiogenic potential, reducing efferocytosis, and improving support of CD8+ T cell activity. Mechanistically, different AKT isoforms are involved, through both PI3K-dependent and PI3K-independent mechanisms. Highlighting the clinical relevance of our findings are correlations between ABCA1 in macrophages and angiogenic potential, VEGFA , and CD8 T cell abundance and activity. The culmination of these activities was demonstrated through increased tumor growth and metastasis in mice lacking MC-expressed ABCA1. Tumors grown in these mice were also more resistant to immune therapy. Therefore, modulating ABCA1 activity within MCs may represent a previously unidentified approach to immune therapy.

9 June 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
KRK C Rajendra
K C Rajendra
RCRuiying Cheng
Ruiying Cheng
SZSihang Zhou
Sihang Zhou
SLSimon Lizarazo
Simon Lizarazo
DSDuncan Smith
Duncan Smith
KBKevin Van Bortle
Kevin Van Bortle
RNA polymerase (Pol) I, II, and III are most commonly described as having distinct roles in synthesizing ribosomal RNA (rRNA), messenger RNA (mRNA), and specific small noncoding (nc)RNAs, respectively. This delineation of transcriptional responsibilities is not definitive, however, as evidenced by instances of Pol II recruitment to genes conventionally transcribed by Pol III, including the co-transcription of RPPH1 - the catalytic RNA component of RNase P. A comprehensive understanding of the interplay between RNA polymerase complexes remains lacking, however, due to limited comparative analyses for all three enzymes. To address this gap, we applied a uniform framework for quantifying global Pol I, II, and III occupancies that integrates currently available human RNA polymerase ChIP-seq datasets. Occupancy maps are combined with a comprehensive multi-class promoter set that includes protein-coding genes, noncoding genes, and repetitive elements. While our genomic survey appropriately identifies recruitment of Pol I, II, and III to canonical target genes, we unexpectedly discover widespread recruitment of the Pol III machinery to promoters of specific protein-coding genes, supported by colocalization patterns observed for several Pol III-specific subunits. We show that Pol III-occupied Pol II promoters are enriched for small, nascent RNA reads terminating in a run of 4 Ts, a unique hallmark of Pol III transcription termination and evidence of active Pol III activity at these sites. Pol III disruption differentially modulates the expression of Pol III-occupied coding genes, which are functionally enriched for ribosomal proteins and genes broadly linked to unfavorable outcomes in cancer. Our map also identifies additional, currently unannotated genomic elements occupied by Pol III with clear signatures of nascent RNA species that are sensitive to disruption of La (SSB) - a Pol III-related RNA chaperone protein. These findings reshape our current understanding of the interplay between Pols II and III and identify potentially novel small ncRNAs with broad implications for gene regulatory paradigms and RNA biology.

25 November 2025 in Nature Communications
Verified
Journal Article
Open access
SZSihang Zhou
Sihang Zhou
SLSimon Lizarazo
Simon Lizarazo
SCSandip Chorghade
Sandip Chorghade
LMLeela Mouli
Leela Mouli
RCRuiying Cheng
Ruiying Cheng
KBKevin Van Bortle
Kevin Van Bortle
Expansion of RNA polymerase III (Pol III) activity in cancer can activate the transcription of typically silent small RNA genes, including snaR-A (small NF90-associated RNA isoform A), a hominid-specific noncoding RNA that promotes cell proliferation through unclear mechanisms. Here, we show that snaR-A interacts with mRNA splicing factors, including the U2 small nuclear ribonucleoprotein (snRNP) subunit SF3B2, and localizes near subnuclear foci enriched in splicing machinery. Overexpression of snaR-A increases intron retention, a hallmark of inefficient splicing, whereas its depletion enhances splicing of mRNAs characterized by high U2 snRNP occupancy and nuclear speckle proximity. These improvements in splicing coincide with reduced cell proliferation, consistent with tumor-level patterns linking snaR-A to growth in primary cancers. Together, these findings identify snaR-A as a molecular antagonist of splicing and potential disease driver in cancer. We propose that snaR-A-related splicing perturbation may phenocopy splicing defects attributed to U2 snRNP mutations in cancer, eliciting an alternative, non-mutational mechanism of splicing dysregulation during tumorigenesis.

13 December 2025 in bioRxiv
Verified
Preprint
Open access
RCRuiying Cheng
Ruiying Cheng
RCRajendra K C
Rajendra K C
SLSimon Lizarazo
Simon Lizarazo
JYJunmeng Yuan
Junmeng Yuan
SZSihang Zhou
Sihang Zhou
KBKevin Van Bortle
Kevin Van Bortle
RNA polymerase III (Pol III) produces noncoding RNAs involved in diverse cellular activities, including translation (tRNA, 5S rRNA, 7SL RNA), RNA processing (U6 snRNA, RPPH1, RMRP), and transcription regulation (7SK snRNA). In this way, Pol III activity must be broadly coupled with cellular demands for protein accumulation and growth, increasing in response to nutrient availability and decreasing during differentiation and exit from proliferation. However, the currently established mechanisms of Pol III regulation remain relatively limited, due in part to the few Pol III-centered protein-protein interaction (PPI) studies performed to date. To address this gap, we first investigated PPIs shared by multiple Pol III subunits to under-stand the macromolecular interactome of Pol III, with special attention directed at potential regulatory candidates. Our proteomic survey uncovers interactions between Pol III and the NuRD (Nucleosome Remodeling and Deacetylase) complex. Taken further, we show that NuRD localizes to active Pol III-transcribed genes and that its recruitment is Pol III-dependent but nonrandom, with peak occupancy and regulatory hallmarks converging on tRNA gene clusters associated with notably high expression levels. Inhibiting NuRD-associated histone deacetylase function reduces Pol III transcription at these sites, suggesting NuRD restricts Pol III and thereby modulates the global dynamic range of Pol III-derived RNA species. These findings are congruent with the transcriptionally repressive nature of NuRD and bring-to-light a new regulatory mechanism that may couple signaling events and changes in metabolic needs with the dynamic availability of specific tRNA pools.

13 October 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
KRK C Rajendra
K C Rajendra
SZSihang Zhou
Sihang Zhou
RCRuiying Cheng
Ruiying Cheng
MPMarco Andres Penaherrera
Marco Andres Penaherrera
SLSimon Lizarazo
Simon Lizarazo
KBKevin Van Bortle
Kevin Van Bortle
Protein-protein interactions (PPIs) are fundamental to the regulation and function of all cellular processes, yet our current understanding of the human interactome is limited by the specific PPI-related experiments performed to date. Moreover, whereas proteins with minimal research interest may have relatively few interaction-probing studies, other factors such as cancer related proteins are frequently represented in PPI studies, producing a highly uneven bias across current PPI data. Here, we apply effective conductance – a concept from circuit theory – to infer proximity relationships across all individual protein pairs on the basis of 1.2 million reported human PPI observations. Using a reciprocal analysis framework built on effective conductance, we identify statistically meaningful interactions within the network while otherwise filtering nonrelevant associations that are abundant in proteins with strong popularity bias. While this approach helps clarify the structural and functional properties of both minimally and maximally connected proteins, we further compute an interaction index between all macromolecular, multi-subunit complexes based on underlying protein-protein conductance scores. Leveraging this framework, which we name CoBRAA (Conductance-Based Reciprocal Association Analysis), we highlight unexpected findings, such as evidence that DNA-dependent RNA polymerase I, II, and III are characterized by surprisingly pervasive cross-complex interactions between enzyme-specific subunits, suggesting a potential for crosstalk between all three RNA polymerases. We further introduce CoBRAA as an open-access research tool that enables custom, user-specified exploration of both protein- and macromolecular-level interactions. We expect this resource to facilitate broader investigation and hypothesis generation across a wide range of proteins, pathways, and macromolecular systems.